| An Antibody-armored Dendritic Cell in Patients With Solid Tumors (NCT07479667) | Shanghai Cell Therapy Group Co.,Ltd | 2026-02-05 |
| An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases (NCT07174843) | Shanghai Cell Therapy Group Co.,Ltd | 2025-09-01 |
| Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors (NCT07146672) | Shanghai Cell Therapy Group Co.,Ltd | 2025-07-31 |
| A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma (NCT06732232) | Shanghai Cell Therapy Group Co.,Ltd | 2024-12-12 |
| A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL) (NCT06446128) | Shanghai Cell Therapy Group Co.,Ltd | 2024-05-07 |
| An Exploratory Study by Fast CAR T Cells (NCT06327997) | Shanghai Cell Therapy Group Co.,Ltd | 2024-03-07 |
| The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults (NCT06224296) | Shanghai Cell Therapy Group Co.,Ltd | 2024-03-01 |
| The Exploratory Study on the Biological Function of Dendritic Cells In Vivo Supported by Nicotinamide Mononucleotide (Vital NAD) (NCT06036355) | Shanghai Cell Therapy Group Co.,Ltd | 2023-09-30 |
| Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors (NCT05944185) | Shanghai Cell Therapy Group Co.,Ltd | 2023-09-01 |
| The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults. (NCT05984550) | Shanghai Cell Therapy Group Co.,Ltd | 2023-08-01 |
| Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery (NCT06015269) | Shanghai Cell Therapy Group Co.,Ltd | 2023-08-01 |
| The Exploratory Study on the Baseline Level of NAD+/NADH in Peripheral Blood Samples of Different Gender and Age Groups of Healthy Adults. (NCT05997628) | Shanghai Cell Therapy Group Co.,Ltd | 2023-08-01 |
| An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells (NCT06249256) | Shanghai Cell Therapy Group Co.,Ltd | 2023-06-01 |
| Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors (NCT06248697) | Shanghai Cell Therapy Group Co.,Ltd | 2023-01-01 |
| Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors (NCT05089266) | Shanghai Cell Therapy Group Co.,Ltd | 2021-11-30 |
| αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors (NCT04503980) | Shanghai Cell Therapy Group Co.,Ltd | 2020-03-26 |
| Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma (NCT04250324) | Shanghai Cell Therapy Group Co.,Ltd | 2019-11-19 |